Einstein-Mount Sinai Diabetes Research Center

Pilot & Feasibility Study Program

Contact Information

Streamson Chua, MD, PhD


FUNDS ARE AVAILABLE FOR DIABETES-RELATED RESEARCHThe Einstein-Mt. Sinai Diabetes Research Center (ES-DRC) announce the availability of Pilot and Feasibility awards (up to $50,000 annually for up to two years) for new projects that explore a diabetes-related concept. Basic and translational projects related to diabetes are eligible. These funds are intended to enable investigators from Einstein, Mt. Sinai, and other affiliated NYC Institutions to generate preliminary data so as to provide the basis for seeking extramural funding of their project. Pilot and feasibility funds are not intended to support or supplement ongoing diabetes research programs. Recipients are required to hold the rank of Assistant Professor or higher at the time of the award.

Eligibility (in order of priority)

This program is designed to support:

  1. New investigators with interests in diabetes or related metabolic and endocrine disorders. Included in this category are junior investigators shifting from mentor based research to an independent career. Meritorious applications from new investigators receive priority for funding.
  2. Established Faculty in other areas who wish to apply their expertise to diabetes research
  3. Diabetes Center members who wish to explore a new area of research that constitutes a substantive departure from their on-going work.


A proposed pilot and feasibility study should present a testable hypothesis and clearly delineate the question being asked, detail the procedure to be followed, and discuss how the data will be analyzed. The budget for the first year (of a possible two-year funding period) can be up to $50,000. Requests for institutional indirect costs are prohibited and salary support for the investigator is generally not provided, except under circumstances that must be pre-approved before submission. Renewal for a second year of funding is contingent on adequate progress. Recipients are required to submit a brief progress report and present their research progress at one of the weekly Diabetes Research Center “Work in Progress” Seminars.

In the interest of improving interactions among faculty, pilot studies that are translational in nature, utilize human tissues and involve collaboration between a laboratory and clinical/translational investigator, will be given the highest priority.

No internal grant forms or approval signatures are necessary in order to submit an application. However, if IRB approval is needed for protection of human subjects, then applicants should apply for that approval at the time the proposal is submitted. Submit your application electronically as an e-mail attachment to fran.taibi@einstein.yu.edu by February 22, 2018.

Your application must include an abstract, budget, a research plan that does not exceed 5 pages, other support data, and NIH biosketches for all key personnel. Provide these components as a single Word or PDF document. If PDF format is used, also include a copy of the abstract in Word. Please use the NIH PHS 398 grant application forms which can be downloaded from the NIH website: website 

The start date for funding of successful applications is anticipated to be June 1, 2018.

Questions concerning this program should be directed to Streamson Chua, M.D. Ph.D.

Jeffrey Pessin, Ph.D.
Director, ES-DRC

Click here to log in